Share on LinkedInShare on LinkedIn

ARTICLE · 14 OCTOBER 2015

Australian High Court rules against gene patents

The High Court has unanimously ruled that isolated naturally occurring nucleic acids are not patentable subject matter.

AustraliaIntellectual Property

The High Court of Australia has unanimously ruled that isolated naturally occurring nucleic acids are not patentable subject matter in Australia. This decision overturns the earlier ruling of the Federal Court and the unanimous decision of the Full Federal Court.

The present case results from a legal challenge to Myriad's Australian patent, 686004 from breast cancer survivor, Yvonne D'Arcy. Commentary in relation to the primary Federal Court decision can be found here and the Full Federal Court decision can be found here.

KEY POINTS

  • This decision will not reduce the cost of genetically-based diagnostic tests in Australia.
  • This decision does not enhance the ability of medical researchers to innovate in Australia.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from